April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Visual Function Impairment in the Absence of Diabetic Retinopathy in Type I Diabetes Mellitus
Author Affiliations & Notes
  • A. A. Reis
    Visual Neuroscience Laboratory, IBILI-Faculty of Med-Univ of Coimbra, Coimbra, Portugal
    Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal
  • C. A. Mateus
    Visual Neuroscience Laboratory, IBILI-Faculty of Med-Univ of Coimbra, Coimbra, Portugal
  • P. Melo
    Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal
  • M. Castelo-Branco
    Visual Neuroscience Laboratory, IBILI-Faculty of Med-Univ of Coimbra, Coimbra, Portugal
  • Footnotes
    Commercial Relationships  A.A. Reis, None; C.A. Mateus, None; P. Melo, None; M. Castelo-Branco, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 5058. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. A. Reis, C. A. Mateus, P. Melo, M. Castelo-Branco; Visual Function Impairment in the Absence of Diabetic Retinopathy in Type I Diabetes Mellitus. Invest. Ophthalmol. Vis. Sci. 2010;51(13):5058.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To characterize visual function in type I diabetic patients with preserved visual acuity (VA), with and without early diabetic retinopathy (DR).

Methods: : Visual function was assessed by Multifocal Electroretinography (RetiScan - Roland Consult), Colour Vision (CCT - Cambridge Research Systems) and Frequency-Doubling Perimetry (FDT - Zeiss) in a population of 42 patients (age=26.6+5.3 years) divided into 2 groups: without DR (n=26; VA=1.088+0.128) and with mild nonproliferative DR (n=16; VA=1.093+0.137). Fluorescein angiography was also performed in order to determine the absence or presence of initial vascular lesions. These data were compared with age-matched controls. Non-parametric statistical analysis was performed at a significance cut-off level of p<0.05.

Results: : MfERG yielded a significant decrease in amplitude in all eccentricity rings in both patients groups, when compared with control subjects (p<0.0001). Impaired contrast sensitivity along protan, deutan and tritan chromatic axes (0.0001<p< 0.02) was also observed, except for the Deutan axis which was comparable to performance controls in the group without DR. FDT quadrantic thresholds were also different between controls and patients (0.0009<p<0.002). However, only electrophysiological measures were found to be distinct between patients groups (p=0.04 for all eccentricity rings except the central one), as well as the Deutan contrast sensitivity (p=0.005).

Conclusions: : Impairment in visual function can be observed in type I diabetic patients with preserved VA, even with no clinical signs of DR, suggesting that retinal neuronal changes may also be relevant, even before breakdown of the blood-retinal barrier or onset of vasculopathy.

Keywords: diabetic retinopathy • electroretinography: clinical • color vision 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×